← Back to Clinical Trials
Recruiting NCT06432985

NCT06432985 Smoking Cessation CM for Veterans With or at Risk for Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06432985
Status Recruiting
Phase
Sponsor VA Office of Research and Development
Condition Tobacco Use Disorder
Study Type INTERVENTIONAL
Enrollment 108 participants
Start Date 2025-01-29
Primary Completion 2031-08-15

Trial Parameters

Condition Tobacco Use Disorder
Sponsor VA Office of Research and Development
Study Type INTERVENTIONAL
Phase N/A
Enrollment 108
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-01-29
Completion 2031-08-15
Interventions
Focus GroupContingency ManagementBehavioral Counseling (Cognitive Behavioral Therapy, CBT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Tobacco use among US Veterans poses significant health problems and challenges to their overall well-being. The aim of this project is to evaluate the effectiveness of a program called Contingency Management (CM) in helping Veterans quit smoking during lung cancer screening or cancer care at VA clinics. CM is a behavioral treatment that uses rewards to encourage smoking cessation when verified through biological testing. In the first year, the researchers will develop a mobile CM protocol based on feedback from Veterans and healthcare staff through focus groups. In the second year, they will conduct a pilot study to test the feasibility of the mobile CM program along with counseling and medication for 20 Veterans over a five-week period. The success of the pilot study will determine whether to proceed with a larger randomized controlled trial (RCT) in years three to six, comparing the efficacy of mobile CM with standard treatment. The project will take place at SFVA.

Eligibility Criteria

Inclusion Criteria: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Human Subjects Involvement and Characteristics: This Proof of Concept and Clinical Trial has three stages. The Proof-of-Concept Phase (Years 1-2) includes a Focus Group phase (Year 1) in which the investigators will recruit both Veterans and non-Veterans (VA clinical staff); and a Pilot Study (Year 2) in which the investigators will recruit Veterans in LCS or cancer treatment at San Francisco VA Healthcare System (SFVAHCS). If the Pilot Study is successful, the investigators will recruit Veterans in LCS or cancer treatment for the RCT (Years 3-6). * Focus Groups: For Focus Groups (Year 1), the investigators will recruit both Veterans and VA clinical staff at SFVAHCS. Veterans: * Age 18 years or older * Veteran eligible for VA healthcare * English-speaking * Received SFVAHCS cancer monitoring or treatment or LCS within the past 24 months * Active cigarette s

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology